blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Q2 2025 product update: New features for seamless trial execution

At Sano Genetics, our mission is to make clinical research in precision medicine faster, more inclusive, and more efficient. In our Q2 2025 product webinar, we ...
Continue reading

Introducing the Sano Referral Manager: Bridging the gap from referral to randomization

Clinical trial recruitment is notoriously difficult, and nowhere is this more acute than at the referral stage. When a participant who looks potentially eligibl...
Continue reading

Clinical trial recruitment for rare disease: AI + JIT

Clinical trial recruitment remains one of the most persistent bottlenecks in drug development. Across therapeutic areas, trials routinely face delays, cost over...
Continue reading

Beyond recruitment: Building lasting relationships with trial participants

As clinical trials become more complex and patient populations more diverse, the traditional focus on recruitment alone is no longer enough. Building long-term ...
Continue reading

Building compliance into precision medicine recruitment

In precision medicine trials, recruitment and compliance are interdependent workstreams. Every step that brings a patient closer to enrollment, from digital out...
Continue reading

Clinical trial recruitment: Conversion and compliance

Most clinical trials fail to recruit enough participants on time. In rare disease and genetically stratified studies, the challenge is compounded: the patient p...
Continue reading

The importance of a patient-centric approach to patient recruitment

Patient recruitment efforts are often designed with the best of intentions, incorporating processes that fulfill every regulatory requirement. However, without ...
Continue reading

Key takeaways from an important conversation about IRD research

On October 18th, 2024 20/20 Onsite, Sano Genetics, and Clinical Enrollment announced the launch of a new partnership to offer a comprehensive solution for ident...
Continue reading

Rare disease drug development: Barriers and solutions

Rare disease drug development operates under a unique set of structural constraints. Patient populations are small and dispersed, diagnostic timelines are long,...
Continue reading

Technologies and tools enabling precision patient finding

There are a number of innovative tools and technologies which are enabling precision patient finding. From AI to e-consent, here we explore how they are changin...
Continue reading